Austin, Texas-based Everlywell recently announced the nationwide rollout and commercial availability of Clairity Breast to its users.
The law reflects growing interest in using existing imaging studies to identify cardiovascular disease risk without requiring additional scans, radiation exposure or costs.
Delays in diagnostic resolution—following an abnormal screening mammogram—can lead to patient anxiety, later-stage cancer ...
About half of those surveyed said they have sought further leadership training, with most doing so outside of their ...
Indiana University Health says it is the first hospital system in the U.S. to administer Pixclara, a pharmaceutical used to ...
MRI2CT says its goal is to enable “MRI-only workflows in spine care,” creating detailed models of bone morphology without the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results